Paraneoplastic Syndrome Market Research Report ‚Äď Forecast to 2030

Paraneoplastic Syndrome Market Research Report Information By Type (Cutaneous Paraneoplastic Syndrome and Others), by Diagnosis (Blood Test, Spinal Tap, and Others), by Treatment (Medication and Others), by End User (Hospitals and Others)- Forecast till 2030

ID: MRFR/MED/5062-HCR | 90 Pages | Author: Rahul Gotadki | June 2023         

Paraneoplastic Syndrome Market Speak to Analyst Request a Free Sample

Paraneoplastic Syndrome Market Scenario


The paraneoplastic syndrome market is expected to grow USD 460 Million at a CAGR 5.80 % during the forecast period 2023 to 2030.

A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically seen in the middle-aged population to older population. This syndrome mostly occurs with patients suffering from lung, ovarian, or breast cancers.  

Numerous factors are anticipated to drive the growth of this market such as the increasing prevalence of cancer, consumption of tobacco, unhealthy lifestyle, increasing geriatric population, and increasing occurrence of breast cancer, among women. According to the American Autoimmune Association, 50 million people suffered from autoimmune disorders in the US in 2017.  

Increasing collaborations among various research institutes for the development of novel diagnostic techniques for the diagnosis of the paraneoplastic syndrome are expected to drive the growth of this market.

Despite the drivers, factors such as unfavorable reimbursement scenario and stringent regulatory policies may hamper the growth of the market during the assessment period.

Segmentation

The paraneoplastic syndrome market has been segmented into types, diagnosis, treatment, and end users. Based on types, the market is segmented into cutaneous paraneoplastic syndrome, gastro-intestinal paraneoplastic syndrome, endocrine paraneoplastic syndrome, hematologic paraneoplastic syndrome, renal paraneoplastic syndrome, rheumatologic paraneoplastic syndromes, and neurologic paraneoplastic syndrome.

The market on the basis of diagnosis has been segmented into blood test, spinal tap (lumbar puncture), and

imaging tests. Imaging tests are further sub-segmented into computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and PET plus CT.

The market, by treatment, has been segmented into medication and therapies. Medication is further sub-segmented into corticosteroids, immunosuppressants, anti-seizure medications, plasmapheresis, and intravenous immunoglobulin (IVIg). On the basis of therapy, the market is further sub-segmented into physical therapy and speech therapy.

Based on end-user, the market is segmented into hospitals and clinics, diagnostic centers, and ambulatory care centers.

Key players

Some of the key players in the global paraneoplastic syndrome market are Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation,

York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation.

Regional Market Summary

Global Paraneoplastic Syndromes Market Share (%), by Region, 2018


Paraneoplastic Syndromes Market


Source: Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC)


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The paraneoplastic syndrome market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European paraneoplastic syndrome market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The paraneoplastic syndrome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The paraneoplastic syndrome market in the Middle East and Africa has been segmented into the Middle East and Africa.


Geographically, the Americas is anticipated to dominate the global paraneoplastic syndrome market. The market growth in this region is attributed to the increasing geriatric population with the paraneoplastic disorder, investment in research and development, and technological advancements. However, increasing approval of novel neurological diagnosis tools in this region is boosting the market in this region.


Europe is expected to be the second largest market in the globe owing to the increasing number of geriatric populations, increasing government expenditure for autoimmune disorders, the presence of disposable income, and increasing consumption of tobacco in this region.


Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of paraneoplastic disorder and cancer-related problems in developing countries, increasing disposable income, and growing healthcare expenditure.


The Middle East and Africa is expected to account for the lowest market share in the global paraneoplastic syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.


Global Paraneoplastic Syndrome Market, by Types



  • Cutaneous Paraneoplastic Syndrome

  • Gastro-Intestinal Paraneoplastic Syndrome

  • Endocrine Paraneoplastic Syndrome

  • Hematologic Paraneoplastic Syndromes

  • Renal Paraneoplastic Syndrome

  • Rheumatologic Paraneoplastic Syndromes

  • Neurologic Paraneoplastic Syndrome


Global Paraneoplastic Syndrome Market, by Diagnosis



  • Blood test

  • Spinal tap (lumbar puncture)

  • Imaging tests

  • Computerized tomography (CT)

  • Magnetic resonance imaging (MRI)

  • Positron emission tomography (PET)

  • PET plus CT


Global Paraneoplastic Syndrome Market, by Treatment



  • Medication

  • Corticosteroids

  • Immunosuppressants

  • Anti-seizure medications

  • Medications to enhance nerve to muscle transmission

  • Plasmapheresis

  • Intravenous immunoglobulin (IVIg)

  • Therapies

  • Physical therapy

  • Speech therapy


Global Paraneoplastic Syndrome Market, by End User



  • Hospitals & Clinics

  • Diagnostic Centers

  • Ambulatory Care Centers


Global Paraneoplastic Syndrome Market, by Region



  • Americas



  • North America

  • US

  • Canada

  • South America



  • Europe



  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe



  • Asia-Pacific



  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific



  • Middle East & Africa



  • Middle East

  • Africa


Global Paraneoplastic Syndrome Market, by Key Players



  • Healthineers

  • Koninklijke Philips N.V.

  • General Electric Company

  • Esaote SpA

  • NeuroLogica Corporation

  • Masimo Corporation

  • York Instruments Ltd

  • Neusoft Medical Systems

  • Canon Medical Systems Corporation


Intended Audience



  • Hospitals and clinics

  • Laboratories and associations

  • Healthcare providers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting



Report Scope:

Report Attribute/Metric Details
  Market Size 460 Million
  CAGR 5.80%
  Base Year 2022
  Forecast Period 2030
  Historical Data 2021
  Forecast Units Value (USD Million)
  Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered Types, Diagnosis, Treatment, and End users
  Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation.
  Key Market Opportunities Increasing disposable income Growing healthcare expenditure
  Key Market Drivers Increasing collaborations among various research institutes for the development of novel diagnostic techniques for the diagnosis
 

Frequently Asked Questions (FAQ) :

Ambulatory care centers, diagnostic centers, and hospitals and clinics are the different end users of Paraneoplastic Syndrome Market.

The Americas is expected to lead the Male Breast Cancer Market.

Rising prevalence of cancer and unhealthy lifestyle is boosting market growth.

Unfavourable reimbursement scenario may limit market growth.

Leading players profiled in the Paraneoplastic Syndrome Market include Canon Medical Systems Corporation, Neusoft Medical Systems, York Instruments Ltd., Masimo Corporation, NeuroLogica Corporation, Esaote SpA, General Electric Company, Koninklijke Philips N.V., and Healthineers.

Key Questions Answered

  • ✅ Global Market Outlook
  • ✅ In-depth analysis of global and regional trends
  • ✅ Analyze and identify the major players in the market, their market share, key developments, etc.
  • ✅ To understand the capability of the major players based on products offered, financials, and strategies.
  • ✅ Identify disrupting products, companies, and trends.
  • ✅ To identify opportunities in the market.
  • ✅ Analyze the key challenges in the market.
  • ✅ Analyze the regional penetration of players, products, and services in the market.
  • ✅ Comparison of major players‚Äô financial performance.
  • ✅ Evaluate strategies adopted by major players.
  • ✅ Recommendations
Request Free Sample

Why Choose Market Research Future?

  • ✅ Vigorous research methodologies for specific market.
  • ✅ Knowledge partners across the globe
  • ✅ Large network of partner consultants.
  • ✅ Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • ✅ Trusted by fortune 500 companies/startups/universities/organizations
  • ✅ Large database of 5000+ markets reports.
  • ✅ Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid